Kopran Limited — Flucloxacillin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Flucloxacillin · $1.3M export value · DGFT Verified
Kopran Limited is the #6 Indian exporter of Flucloxacillin with $1.3M in export value and 26 verified shipments. Kopran Limited holds a 3.4% market share in Flucloxacillin exports across 2 countries. The company exports 6 pharmaceutical products worth $7.3M across 5 therapeutic categories.
Kopran Limited — Flucloxacillin Export Profile: Buyers & Destinations
Where Does Kopran Limited Export Flucloxacillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SOUTH AFRICA | $504.4K | 17 | 78.5% |
| PAPUA NEW GUINEA | $138.1K | 9 | 21.5% |
Kopran Limited exports Flucloxacillin to 2 countries. The largest destination is SOUTH AFRICA accounting for 78.5% of Kopran Limited's Flucloxacillin shipments. These destinations reflect Kopran Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Flucloxacillin from Kopran Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO THE ORDER OF | SOUTH AFRICA | $210.0K | 8 |
| TO THE ORDER | PAPUA NEW GUINEA | $172.1K | 7 |
| CITY PHARMACY LIMITEDP O BOX | PAPUA NEW GUINEA | $110.4K | 7 |
| TO THE ORDER OF . | SOUTH AFRICA | $100.0K | 2 |
| TO THE ORDER OF . | SOUTH AFRICA | $50.0K | 2 |
Kopran Limited supplies Flucloxacillin to 5 buyers globally. The largest buyer is TO THE ORDER OF (SOUTH AFRICA), followed by TO THE ORDER (PAPUA NEW GUINEA) and CITY PHARMACY LIMITEDP O BOX (PAPUA NEW GUINEA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Flucloxacillin Export Value and How Much Does Kopran Limited Contribute?
India exported $30.0M worth of Flucloxacillin through 1,146 shipments from 123 suppliers to 44 countries, serving 198 buyers globally. Kopran Limited contributes $1.3M to this total, accounting for 3.4% of India's Flucloxacillin exports. Kopran Limited ships Flucloxacillin to 2 countries through 5 buyers.
What Is the Average Shipment Value for Kopran Limited's Flucloxacillin Exports?
Kopran Limited's average Flucloxacillin shipment value is $50.0K per consignment, based on 26 shipments totaling $1.3M. The largest destination is SOUTH AFRICA (78.5% of Kopran Limited's Flucloxacillin exports).
How Does Kopran Limited Compare to Other Indian Flucloxacillin Exporters?
Kopran Limited ranks #6 among 123 Indian Flucloxacillin exporters with a 3.4% market share. The top 3 exporters are MEDREICH LIMITED ($16.9M), MICRO LABS LIMITED ($4.0M), AUROBINDO PHARMA LTD ($1.7M). Kopran Limited processed 26 shipments to 2 destination countries.
What Flucloxacillin Formulations Does Kopran Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE PHARMACEUTICAL GOODSINDOFLUCLOXACILLIN 250MG FLUCLOXACILLIN CAPSULE 250MG EACH CAPSULE CONTAINS F | $144.4K | 3 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSINDOFLUCLOXACILLIN 250MG (FLUCLOXACILLIN CAPSULE 250MG) | $100.0K | 2 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSINDOFLUCLOXACILLIN 250MG (FLUCLOXACILLIN CAPSULE 250MG) (EACH CAPSULE CONTAINS | $100.0K | 2 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSFLUPEN 250MG CAPSULES FLUCLOXACILLIN CAPSULE 250MG | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS MACROPEN 500MG CAPSULES (AMOXYCILLIN CAPSLULES 250 MG & FLUCLOXACILLIN ** | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS MACROPEN 500MG CAPSULES (AMOXYCILLIN CAPSLULES 250 MG & FLUCLOXACILLIN CAPSULES | $50.0K | 1 |
| HARMLESS MEDICINE/PHARMACEUTICAL GOODS MACROPEN 500MG CAPSULES (AMOXYCILLIN CAPSLULES 250 MG & FLUCLOXACILLIN CAPSULES 2 | $50.0K | 1 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSFLUPEN DRY SYRUP 250MG/5ML FLUCLOXACILLIN ORAL SUSPENSION SYRUP 250 MG/5ML | $39.4K | 3 |
| HARMLESS MEDICINE / PHARMACEUTICAL GOODSFLUPEN DRY SYRUP 125MG/5ML FLUCLOXACILLIN ORAL SUSPENSION SYRUP 125 MG/5ML | $21.1K | 3 |
| HARMLESS MEDICINE PHARMACEUTICAL GOODSFLUPEN DRY SYRUP 125MG 5ML FLUCLOXACILLIN ORAL SUSPENSION SYRUP 125 MG 5ML 1 | $15.7K | 1 |
Kopran Limited exports 18 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE PHARMACEUTICAL GOODSINDOFLUCLOXACILLIN 250 with 3 shipments worth $144.4K.
Regulatory Requirements: Exporting Flucloxacillin to Key Markets
What Kopran Limited must comply with to export Flucloxacillin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Kopran Limited Compare to Nearest Flucloxacillin Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AUROBINDO PHARMA LTD | $1.7M | 43 | 1 | $39.3K |
| 4 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED | $1.4M | 29 | 3 | $50.0K |
| 6 | KOPRAN LIMITED ★ | $1.3M | 26 | 2 | $50.0K |
| 7 | AJANTA PHARMA LIMITED | $860.1K | 76 | 5 | $11.3K |
| 8 | MERIT ORGANICS LIMITED | $755.8K | 21 | 1 | $36.0K |
Kopran Limited ranks #6 among 123 Indian Flucloxacillin exporters. Average shipment value of $50.0K compared to the market average of $243.5K. The closest competitors by value are AUROBINDO PHARMA LTD and MILAN LABORATORIES (INDIA) PRIVATE LIMITED.
Which Indian Ports Ship Flucloxacillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 140 | 12.2% |
| BANGALORE ICD (INWFD6) | 107 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 100 | 8.7% |
| JNPT | 76 | 6.6% |
| BANGALORE ACC (INBLR4) | 69 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 55 | 4.8% |
| SAHAR AIR | 50 | 4.4% |
| BANGALORE AIR | 36 | 3.1% |
About Kopran Limited
Kopran Limited exports 6 products worth $7.3M. Beyond Flucloxacillin, top products include Kit, Enalapril, Clarithromycin, Atenolol, Salmeterol. View the complete Kopran Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Flucloxacillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Flucloxacillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Kopran Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 26 individual customs records matching Kopran Limited exporting Flucloxacillin, covering 18 formulations to 2 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 198+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Flucloxacillin Export Data from Kopran Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Kopran Limited's Flucloxacillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Kopran Limited
Full Company Profile →
6 products · $7.3M total trade · 5 categories
Flucloxacillin Stats
Company Overview
Top Products by Kopran Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Kopran Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Flucloxacillin. For current shipment-level data, contact TransData Nexus.